Autopsy report · NCT01722227
Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Cause of deathFunding or business
“No Funding Received from ADA”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- University at Buffalo
- Sponsor type
- University, hospital or other
- Conditions
- Type 1 Diabetes
- Interventions
- Liraglutide; Placebo
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer
“Funding was not available” - A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
“No funding obtained” - Biofilm Infection in Adults and Children Burn Injury
“did not receive funding” - Brain Sleep Deprivation MRI Effects (BEDTIME)
“Funding was not obtained” - Effects of Steroid Tapering on Functional Capacity and Neurocognition
“Funding not obtained”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.